DexCom earnings beat by $0.03, revenue topped estimates
Hercules Capital, Inc. (NYSE:HTGC), a $3.09 billion market cap company trading at a P/E ratio of 13.31, saw its Chief Operating Officer Christian Follmann recently report transactions involving the company’s common stock. According to the SEC filing, Follmann sold 395 shares on June 5, 2025, at a price of $17.83 per share, totaling $7,042. Following this sale, Follmann retains direct ownership of 120,556 shares. InvestingPro data shows the stock currently trades at $17.87, between its 52-week range of $15.65-$22.04.
On the same day, Follmann also purchased 395 shares at the same price, for a total of $7,042. This acquisition increased Follmann’s direct ownership to 121,212 shares. Notably, this total includes 261 shares acquired through dividend reinvestment on May 20, 2025.
Additionally, Follmann indirectly holds 350 shares through his spouse. These transactions highlight the ongoing adjustments in Follmann’s holdings of Hercules Capital stock.
In other recent news, Hercules Capital announced its Q1 2025 earnings, reporting an earnings per share (EPS) of $0.45, which fell short of the $0.47 forecast by analysts. Despite this slight miss, the company reported a robust total investment income of $119.5 million and a strong return on equity of 15.7%. Hercules Capital also received credit rating upgrades from Morningstar DBRS and Fitch, reflecting confidence in its financial stability. Additionally, the company maintained a quarterly base distribution of $0.40 per share, supplemented by an additional $0.07 per share.
Hercules Capital’s strategic focus on the technology and life sciences sectors continues to drive growth, with these areas representing 53% and 47% of its commitments, respectively. The company also reported a significant increase in net debt portfolio growth, attributed to strong originations and fundings. Looking ahead, Hercules Capital anticipates a Q2 core yield of 12-12.5% and expects prepayment activity to be between $200-$250 million. Despite broader market volatility, the company remains optimistic about its business momentum.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.